Avadel said it received an unsolicited acquisition proposal from Lundbeck worth up to $23 per share, potentially exceeding its existing deal with Alkermes, which offered up to $20 per share. The board stated that the new bid could be superior, though it has not made a final determination and continues to support the Alkermes agreement for now.